Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.

Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, Jiang W, Mudd J, Schacker T, Funderburg NT, Pilch-Cooper HA, Debernardo R, Rabin RL, Lederman MM, Harding CV.

PLoS One. 2013;8(2):e56527. doi: 10.1371/journal.pone.0056527.

2.

Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.

Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM.

PLoS One. 2012;7(1):e30306. doi: 10.1371/journal.pone.0030306.

3.

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

Fraietta JA, Mueller YM, Yang G, Boesteanu AC, Gracias DT, Do DH, Hope JL, Kathuria N, McGettigan SE, Lewis MG, Giavedoni LD, Jacobson JM, Katsikis PD.

PLoS Pathog. 2013;9(10):e1003658. doi: 10.1371/journal.ppat.1003658.

4.

Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.

Kader M, Smith AP, Guiducci C, Wonderlich ER, Normolle D, Watkins SC, Barrat FJ, Barratt-Boyes SM.

PLoS Pathog. 2013;9(7):e1003530. doi: 10.1371/journal.ppat.1003530.

5.

Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.

Rodriguez B, Lederman MM, Jiang W, Bazdar DA, Gàrate K, Harding CV, Sieg SF.

AIDS. 2006 Jun 26;20(10):1379-89.

PMID:
16791012
6.

Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection.

Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T.

Hum Immunol. 2003 May;64(5):497-504.

PMID:
12691700
7.

Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a.

Lee YJ, Zhang X, Vazquez E, Shivasabesan G, Young HA, Murphy A, Wang H, Suffredini AF, Siebenlist U, Kottilil S.

J Interferon Cytokine Res. 2014 Jan;34(1):28-34. doi: 10.1089/jir.2013.0032.

8.

Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.

Critchfield JW, Young DH, Hayes TL, Braun JV, Garcia JC, Pollard RB, Shacklett BL.

PLoS One. 2008;3(10):e3577. doi: 10.1371/journal.pone.0003577.

9.

[Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].

Zheng YH, He Y, Yang X, Gong GZ, Zhou HY, Zhang CY, Zhou W, Huang L, Ding PP, Li H.

Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):741-4. Chinese.

PMID:
16248945
10.

Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression.

Hardy GA, Sieg SF, Rodriguez B, Jiang W, Asaad R, Lederman MM, Harding CV.

Blood. 2009 May 28;113(22):5497-505. doi: 10.1182/blood-2008-11-190231.

11.

Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients.

Sandberg JK, Falconer K, Gonzalez VD.

Virulence. 2010 May-Jun;1(3):177-9. doi: 10.4161/viru.1.3.11206.

PMID:
21178437
12.
13.

Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.

D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, Wilson CC, Connick E, Palmer BE.

J Immunol. 2007 Aug 1;179(3):1979-87.

14.

HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Resino S, Galán I, Pérez A, León JA, Seoane E, Gurbindo D, Muñoz-Fernandez MA.

Clin Exp Immunol. 2004 Sep;137(3):570-7.

15.

Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.

Givens TS, DuChateau BK, Boomer JS, Westerman MP, Gilman-Sachs A, Beaman KD.

Clin Diagn Lab Immunol. 1999 Nov;6(6):872-7.

16.

HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.

Zhuang Y, Wei X, Li Y, Zhao K, Zhang J, Kang W, Sun Y.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1044-51. doi: 10.1089/AID.2011.0318.

PMID:
22214236
17.

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.

Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, Carr A, Cooper DA.

AIDS. 2000 Dec 1;14(17):2643-51.

PMID:
11125882
18.
19.

Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.

Moens B, Pannecouque C, López G, Talledo M, Gotuzzo E, Khouri R, Bittencourt A, Farré L, Galvão-Castro B, Vandamme AM, Van Weyenbergh J.

Virol J. 2012 Aug 23;9:171. doi: 10.1186/1743-422X-9-171.

20.

[Characterization of HIV-1 Gag-specific proliferative T cell responses in Chinese HIV-1 infected patients].

Wang Q, Shang H, Wang YN, Zhang ZN, Jiang YJ.

Zhonghua Yi Xue Za Zhi. 2006 Nov 28;86(44):3099-103. Chinese.

PMID:
17313759

Supplemental Content

Support Center